Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.

<h4>Introduction</h4>HIV-1 viral Load (VL) testing is recommended for the monitoring of antiretroviral treatment. Dried Blood Spots (DBS) are an effective sample type in resource limited settings, where safe phlebotomy and reliable shipping are hard to guarantee. In HIV high burden count...

Full description

Bibliographic Details
Main Authors: Matilu Mwau, Sven Schaffer, Humphrey Kimani, Purity Kasiano, Francis Ogolla, Elizabeth Ajema, Scriven Adoyo, Ednah Nyairo, Norah Saleri, Sangeetha Vijaysri Nair
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0269838
_version_ 1811281318236913664
author Matilu Mwau
Sven Schaffer
Humphrey Kimani
Purity Kasiano
Francis Ogolla
Elizabeth Ajema
Scriven Adoyo
Ednah Nyairo
Norah Saleri
Sangeetha Vijaysri Nair
author_facet Matilu Mwau
Sven Schaffer
Humphrey Kimani
Purity Kasiano
Francis Ogolla
Elizabeth Ajema
Scriven Adoyo
Ednah Nyairo
Norah Saleri
Sangeetha Vijaysri Nair
author_sort Matilu Mwau
collection DOAJ
description <h4>Introduction</h4>HIV-1 viral Load (VL) testing is recommended for the monitoring of antiretroviral treatment. Dried Blood Spots (DBS) are an effective sample type in resource limited settings, where safe phlebotomy and reliable shipping are hard to guarantee. In HIV high burden countries, high throughput assays can improve access to testing services. The Hologic Aptima HIV-1 Quant Dx Assay (Aptima Assay) is a high throughput assay that runs on the CE-IVD approved Panther platform. The objectives of this study were to assess the performance characteristics of Aptima for VL monitoring using plasma and venous DBS specimens and to determine the stability of HIV-1 RNA in DBS.<h4>Materials and methods</h4>This was a cross-sectional study of 2227 HIV infected adults visiting health facilities in Nairobi and Busia, Kenya. Each provided a venous blood sample; plasma was prepared from 1312 samples while paired DBS samples and plasma were prepared from the remaining 915 samples. The agreement between the Aptima assay and the Abbott RealTime HIV-1 Assay (Abbott RT) was analysed by comparing the HIV-1 VL in both assays at the medical decision point of 1000 copies/mL. To assess stability of HIV-1 RNA in DBS, VL in DBS spotted on day 0 were compared with that from the same DBS card after 21 days of storage at room temperature.<h4>Results</h4>Overall, 436 plasma samples had quantifiable results in both Aptima and Abbott RT. The agreement between the two assays at 1000 copies/mL was 97.48% with a Pearson's correlation coefficient (r) of 0.9589 and gave a mean bias of 0.33 log copies/mL on Bland-Altman analysis. For fresh DBS, the agreement in both assays was 94.64% at 1000 copies/mL, with an r of 0.8692 and a mean bias of 0.35 log copies/mL. The overall agreement between DBS tested in Aptima on day 0 versus day 21 was 95.71%, with a mean bias of -0.154.<h4>Conclusion</h4>The Aptima HIV-1 Quant Dx assay is an accurate test for VL monitoring of HIV-1 using DBS and plasma sample types in Kenya.
first_indexed 2024-04-13T01:31:33Z
format Article
id doaj.art-e50ebdceafb4476cace2c11da6574444
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T01:31:33Z
publishDate 2022-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e50ebdceafb4476cace2c11da65744442022-12-22T03:08:30ZengPublic Library of Science (PLoS)PLoS ONE1932-62032022-01-01178e026983810.1371/journal.pone.0269838Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.Matilu MwauSven SchafferHumphrey KimaniPurity KasianoFrancis OgollaElizabeth AjemaScriven AdoyoEdnah NyairoNorah SaleriSangeetha Vijaysri Nair<h4>Introduction</h4>HIV-1 viral Load (VL) testing is recommended for the monitoring of antiretroviral treatment. Dried Blood Spots (DBS) are an effective sample type in resource limited settings, where safe phlebotomy and reliable shipping are hard to guarantee. In HIV high burden countries, high throughput assays can improve access to testing services. The Hologic Aptima HIV-1 Quant Dx Assay (Aptima Assay) is a high throughput assay that runs on the CE-IVD approved Panther platform. The objectives of this study were to assess the performance characteristics of Aptima for VL monitoring using plasma and venous DBS specimens and to determine the stability of HIV-1 RNA in DBS.<h4>Materials and methods</h4>This was a cross-sectional study of 2227 HIV infected adults visiting health facilities in Nairobi and Busia, Kenya. Each provided a venous blood sample; plasma was prepared from 1312 samples while paired DBS samples and plasma were prepared from the remaining 915 samples. The agreement between the Aptima assay and the Abbott RealTime HIV-1 Assay (Abbott RT) was analysed by comparing the HIV-1 VL in both assays at the medical decision point of 1000 copies/mL. To assess stability of HIV-1 RNA in DBS, VL in DBS spotted on day 0 were compared with that from the same DBS card after 21 days of storage at room temperature.<h4>Results</h4>Overall, 436 plasma samples had quantifiable results in both Aptima and Abbott RT. The agreement between the two assays at 1000 copies/mL was 97.48% with a Pearson's correlation coefficient (r) of 0.9589 and gave a mean bias of 0.33 log copies/mL on Bland-Altman analysis. For fresh DBS, the agreement in both assays was 94.64% at 1000 copies/mL, with an r of 0.8692 and a mean bias of 0.35 log copies/mL. The overall agreement between DBS tested in Aptima on day 0 versus day 21 was 95.71%, with a mean bias of -0.154.<h4>Conclusion</h4>The Aptima HIV-1 Quant Dx assay is an accurate test for VL monitoring of HIV-1 using DBS and plasma sample types in Kenya.https://doi.org/10.1371/journal.pone.0269838
spellingShingle Matilu Mwau
Sven Schaffer
Humphrey Kimani
Purity Kasiano
Francis Ogolla
Elizabeth Ajema
Scriven Adoyo
Ednah Nyairo
Norah Saleri
Sangeetha Vijaysri Nair
Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
PLoS ONE
title Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
title_full Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
title_fullStr Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
title_full_unstemmed Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
title_short Comparison of the performance of Aptima HIV-1 Quant Dx Assay with Abbott RealTime HIV Assay for viral load monitoring using plasma and Dried Blood Spots collected in Kenya.
title_sort comparison of the performance of aptima hiv 1 quant dx assay with abbott realtime hiv assay for viral load monitoring using plasma and dried blood spots collected in kenya
url https://doi.org/10.1371/journal.pone.0269838
work_keys_str_mv AT matilumwau comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT svenschaffer comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT humphreykimani comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT puritykasiano comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT francisogolla comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT elizabethajema comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT scrivenadoyo comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT ednahnyairo comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT norahsaleri comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya
AT sangeethavijaysrinair comparisonoftheperformanceofaptimahiv1quantdxassaywithabbottrealtimehivassayforviralloadmonitoringusingplasmaanddriedbloodspotscollectedinkenya